AGP Picks
View all

Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx

JERSEY CITY, N.J., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading data analytics and technology provider to the global insurance industry, today issued the following statement in response to the Delaware Chancery Court ruling regarding AccuLynx:

“We appreciate the expedited response from the court but strongly disagree with the decision. It is possible to appeal, among other next steps, and we are evaluating our options at this time.”

About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work. For more, visit Verisk.com and the Verisk Newsroom.


Investor Relations  
Stacey Brodbar
Senior Vice President, Finance and Investor Relations
Verisk 
201-469-4327 
stacey.brodbar@verisk.com

Media 
Ali Herbert
Verisk
ali.herbert@verisk.com
201-469-3998

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Delaware News Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.